📊 SBRA Key Takeaways
Is Sabra Health Care REIT, Inc. (SBRA) a Good Investment?
Revenue doubled YoY but net income grew only 0.1%, indicating severe earnings quality deterioration and operational inefficiency. The combination of poor capital returns (ROE 1.5%, ROA 0.7%), tight interest coverage (1.4x), and concerning leverage despite strong FCF suggests the business is not converting growth into shareholder value.
Sabra Health Care REIT, Inc. Key Strengths (SBRA)
- Exceptional FCF generation at 44.4% FCF margin with $98.4M absolute FCF
- Robust revenue growth of 117% YoY demonstrates significant portfolio expansion
- Moderate debt-to-equity ratio of 0.96x provides balance sheet flexibility
- Healthy operating margins of 17.7% on a standalone basis
SBRA Stock Risks: Sabra Health Care REIT, Inc. Investment Risks
- Revenue growth decoupled from earnings growth (117% vs 0.1%) indicates structural profitability issues or integration headwinds
- Critically low ROE (1.5%) and ROA (0.7%) reflect severe capital inefficiency despite margin expansion
- Interest coverage of 1.4x is dangerously tight; minimal earnings deterioration could impair debt service capacity
- Elevated leverage ($2.7B long-term debt) combined with weak coverage ratios creates refinancing risk
Key Metrics to Watch
- Net income growth relative to revenue growth in next quarter; must stabilize above 10% growth
- Interest coverage ratio; must improve above 2.0x to ensure financial stability
- Return on equity and return on assets; target minimum 3% ROA and 5% ROE for REIT sector
- Operating expense ratios; identify whether recent dilution is temporary integration cost or permanent structural issue
Sabra Health Care REIT, Inc. (SBRA) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The 44.4% free cash flow margin provides substantial flexibility for dividends, buybacks, and strategic investments. The current ratio below 1.0x warrants monitoring of short-term liquidity.
SBRA Profit Margin, ROE & Profitability Analysis
SBRA vs Real Estate Sector: How Sabra Health Care REIT, Inc. Compares
How Sabra Health Care REIT, Inc. compares to Real Estate sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Sabra Health Care REIT, Inc. Stock Overvalued? SBRA Valuation Analysis 2026
Based on fundamental analysis, Sabra Health Care REIT, Inc. has mixed fundamental signals relative to the Real Estate sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Sabra Health Care REIT, Inc. Balance Sheet: SBRA Debt, Cash & Liquidity
SBRA Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Sabra Health Care REIT, Inc.'s revenue has grown significantly by 129% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.06 reflects profitable operations.
SBRA Revenue Growth, EPS Growth & YoY Performance
SBRA Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $77.4M | $40.3M | $0.16 |
| Q3 2025 | $73.7M | $22.5M | $0.09 |
| Q2 2025 | $67.9M | $24.0M | $0.10 |
| Q1 2025 | $66.0M | $26.3M | $0.11 |
| Q3 2024 | $59.7M | -$3.4M | $-0.01 |
| Q2 2024 | $58.4M | $11.7M | $0.05 |
| Q1 2024 | $56.7M | -$9.5M | $-0.04 |
| Q3 2023 | $47.6M | -$3.4M | $-0.01 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Sabra Health Care REIT, Inc. Dividends, Buybacks & Capital Allocation
SBRA SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Sabra Health Care REIT, Inc. (CIK: 0001492298)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SBRA
What is the AI rating for SBRA?
Sabra Health Care REIT, Inc. (SBRA) has an AI grade of C with 68% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SBRA's key strengths?
Claude: Exceptional FCF generation at 44.4% FCF margin with $98.4M absolute FCF. Robust revenue growth of 117% YoY demonstrates significant portfolio expansion.
What are the risks of investing in SBRA?
Claude: Revenue growth decoupled from earnings growth (117% vs 0.1%) indicates structural profitability issues or integration headwinds. Critically low ROE (1.5%) and ROA (0.7%) reflect severe capital inefficiency despite margin expansion.
What is SBRA's revenue and growth?
Sabra Health Care REIT, Inc. reported revenue of $221.8M.
Does SBRA pay dividends?
Sabra Health Care REIT, Inc. pays dividends, with $75.7M distributed to shareholders in the trailing twelve months.
Where can I find SBRA SEC filings?
Official SEC filings for Sabra Health Care REIT, Inc. (CIK: 0001492298) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SBRA's EPS?
Sabra Health Care REIT, Inc. has a diluted EPS of $0.16.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is SBRA's fundamental grade?
Based on our AI fundamental analysis in May 2026, Sabra Health Care REIT, Inc. has a C grade with 68% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is SBRA stock overvalued or undervalued?
Valuation metrics for SBRA: ROE of 1.5% (sector avg: 8%), net margin of 18.4% (sector avg: 20%). Compare these metrics with sector averages to assess valuation.
What is SBRA's AI grade for 2026?
Our dual AI analysis gives Sabra Health Care REIT, Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SBRA's free cash flow?
Sabra Health Care REIT, Inc.'s operating cash flow is $98.4M, with capital expenditures of N/A. FCF margin is 44.4%.
How does SBRA compare to other Real Estate stocks?
Vs Real Estate sector averages: Net margin 18.4% (avg: 20%), ROE 1.5% (avg: 8%), current ratio N/A (avg: 1.5).